Pharm

Nesiritide

search

Nesiritide, Natrecor, Recombinant Human Brain Natriuretic Peptide

  • Indications
  1. Decomensated Congestive Heart Failure
  • Mechanism
  1. Recombinant Human Brain Natriuretic Peptide
  2. Results in venous and arterial vasodilation
  • Dosing
  1. Bolus: 2 mcg/kg IV bolus
  2. Maintenance: 0.01 mcg/kg/min for 24-48 hours
  • Efficacy
  1. Improves CHF symptoms
  2. Increases mortality within first 30 days
  3. Sackner-Bernstein (2005) JAMA 293:1900-5 [PubMed]
  • Cost
  1. Typical course is 2 vials at $530 per vial
  • Monitoring
  1. Blood Pressure during administration (Hypotension risk)
  2. Serum Creatinine